GLIPITEC M2
TM Tablets combine Glimepiride and Metformin (sustained-release) to provide effective glycemic control in patients with type 2 diabetes mellitus. Glimepiride enhances pancreatic insulin secretion, while Metformin improves insulin sensitivity and reduces hepatic glucose output. This higher-strength combination is beneficial for patients who require tighter glucose control as the disease progresses.
Composition
- Glimepiride 2TM mg
- Metformin Hydrochloride 500 mg (Sustained Release)
Key Features & Benefits
- Enhanced Glycemic Control: Higher strength for improved blood glucose management
- Dual Mechanism Action: Combines insulin secretion with insulin sensitization
- Sustained-Release Benefit: Ensures gradual release and better gastrointestinal tolerability
- Progressive Therapy Option: Suitable for patients needing dose escalation
- Convenient Regimen: Reduces pill burden and improves adherence
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Preferably taken with meals to reduce gastrointestinal side effects
- Regular monitoring of blood glucose levels is recommended
Safety Information
- Increased risk of hypoglycemia—monitor blood sugar regularly
- Use cautiously in elderly patients and those with renal or hepatic impairment
- Avoid skipping meals during treatment
- Seek medical advice if any unusual symptoms occur
Storage Instructions
- Store in a cool and dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
